论文部分内容阅读
目的研究注射用骨肽与阿仑膦酸钠用于骨质疏松症治疗的临床效果。方法 100例骨质疏松症患者,随机分为观察组与对照组,各50例。对照组采用阿仑膦酸钠联合钙尔奇D进行治疗,观察组患者采用注射用骨肽联合阿仑膦酸钠进行治疗,比较两组患者的临床疗效。结果观察组患者的临床治疗总有效率为94.00%,显著高于对照组的64.00%,差异有统计学意义(P<0.05)。治疗前,两组患者Wards三角(Wards)、大粗隆(Troch)及左侧股骨颈(Neek)的骨密度比较,差异无统计学意义(P>0.05)。治疗后,观察组患者Wards、Troch及Neek的骨密度显著高于对照组,差异有统计学意义(P<0.05)。结论注射用骨肽与阿仑膦酸钠用于骨质疏松症治疗的临床效果显著,值得广泛推广。
Objective To study the clinical effect of injecting bone peptide and alendronate in the treatment of osteoporosis. Methods 100 cases of osteoporosis patients were randomly divided into observation group and control group, 50 cases each. The control group was treated with alendronate combined with Calcium D, and the observation group was treated with injection of bone peptide combined with alendronate sodium. The clinical efficacy was compared between the two groups. Results The total effective rate of clinical treatment in observation group was 94.00%, which was significantly higher than that in control group (64.00%), the difference was statistically significant (P <0.05). Before treatment, there was no significant difference in bone mineral density between Wards, Troch and Neek in the two groups (P> 0.05). After treatment, the BMD of Wards, Troch and Neek in the observation group was significantly higher than that of the control group (P <0.05). Conclusion The clinical effect of injection of bone peptide and alendronate in the treatment of osteoporosis is significant and worthy of widespread promotion.